Kent Emry, CEO of Fresh Start Private, Updates Shareholders on Pending Name Change and More in a New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, Dec. 18, 2013 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. announced today that a new audio interview with Fresh Start Private Management, Inc. CEYY, a leader in alcohol treatment and rehabilitation programs, is now available. The interview can be heard at http://smallcapvoice.com/blog/12-16-13-smallcapvoice-interview-with-fresh-start-private-management-ceyy

Kent Emry, CEO of Fresh Start Private Management, Inc., called in to SmallCapVoice.com to go over the pending company name change, his recent purchases of CEYY shares in the open market, the completion of the Connecticut licensing agreement, and much more.

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About Fresh Start Private

Fresh Start Private Management, Inc. CEYY is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, please visit www.freshstartprivate.com

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.